- Telehealth Visits
Anthony A. Portale, MD
Nephrology • Pediatric Nephrology- Telehealth Visits
Anthony A. Portale, MD
Nephrology • Pediatric Nephrology- Telehealth Visits
On this page
About me
Dr. Anthony A. Portale is a specialist in pediatric kidney disorders. His expertise encompasses genetic diseases of the kidneys and renal tubular system, disorders of bone and mineral metabolism, and acute kidney failure.
Portale's research, which has funding from the National Institutes of Health, focuses on genetic and acquired disorders of calcium, phosphorus and vitamin D metabolism and bone diseases in children. He has contributed more than 80 publications to the medical and scientific literature on these topics.
Portale earned his medical degree at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo, part of the State University of New York system. He completed a residency in pediatrics at the John R. Oishei Children's Hospital and a fellowship in pediatric nephrology at UCSF.
Education
Board Certification
- Pediatric Nephrology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Nephrology, UCSF School of Medicine -GME
Residency
- Pediatrics, Women & Childrens Hospital of Buffalo-Kaleida
Internship
- Pediatrics, Women & Childrens Hospital of Buffalo-Kaleida
School
- MD, State University of New York (SUNY) at Buffalo
Care Keywords
Services
- Nephrology
- Pediatric Nephrology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.